Qualitas Funds has announced that Univo IRB has been added to the Qualitas Funds IV portfolio.
Established in 2016, Univo IRB is an Independent Review Board (IRB) focused on serving biotech and small pharma sectors. The company specializes in the ethical review of Phase I-IV pharmaceutical, device, biologic, behavioral, and psycho-social research. It prioritizes efficiency and promptness in its operations while maintaining a strong focus on advocating for patient rights throughout its processes.
cloud technology axon
AIVORIQ has grown significantly since Alantra PE launched the project....
Capital-Riesgo.es
Subscribe to our newsletter and stay up to date with the latest news and deals!
2013 © Capital-Riesgo.es - Site Developments SL. All Rights Reserved. Terms of Service | Privacy Policy
Articles
Directory
